Diagnostic company’s shares are down 90% since its rapid antigen tests were the first to be approved for Covid-19
QuidelOrtho looks to sell testing unit as PE circles healthcare companies
Diagnostic company’s shares are down 90% since its rapid antigen tests were the first to be approved for Covid-19
